From: Computational analysis of expression of human embryonic stem cell-associated signatures in tumors
Gene sets | #Genes with 10 or more overlapsb | Top 10 overlapping genes |
---|---|---|
hESC exp1 | 308 (81%) | MTHFD2, MCM4, MCM6, LGALS8, PPP2R1B, RFC4, GART, BUB1, LCK, PTPN2 |
hESC exp2 | 26 (65%) | MYBL2, EPHA1, ORC2, DTYMK, PRKD3, NCAPH, ETV4, DSCC1, CDC25A, PWP2 |
hESC exp3 | 38 (79%) | BUB1, DLGAP5, SLC16A1, USP9X, HSPA4, TERF1, PSIP1, PLA2G16, UGP2, BMPR1A |
hESC exp4 | 29 (97%) | SPARC, COL1A2, COL3A1, COL1A1, CD47, COL5A2, KRT18, KRT8, LUM, COL6A3 |
hESC exp5 | 135 (71%) | TCF4, STAT1, GATA3, MAF, MYC, MYBL2, ILF3, SMAD4, FUBP1, GATA2 |
hESC exp6 | 28 (64%) | CD9, IL6ST, PTEN, EDNRB, KIT, NR5A2, IFITM2, CRABP2, NFYC, PODXL |
hESC exp7 | 863 (87%) | GNAS, FN1, SPARC, MCM6, MCM4, TOP2A, COL1A2, COL3A1, RFC4, RAB31 |
hESC exp8 | 11 (50%) | FAS, CKS1B, GJA1, NPM1, TGIF1, HMGA1, DNMT3A, ERH, SOX2, DNMT3B |
hESC exp9 | 21 (78%) | PCNA, CKS1B, FAS, TERF1, GJA1, CCNB1, NPM1, FZD7, SFRP1, HMGA1 |
hESC exp10 | 30 (97%) | PGK1, BAK1, HNRNPA1, EEF1A1, PPIA, GAPDH, GJA1, TMED2, EEF1B2, NPM1 |
hESC exp11 | 749 (75%) | PDE4DIP, FGFR2, CKS2, MTHFD2, SOX4, SLC2A3, STAT1, MAPK1, PSMB2, MCM4 |
Nanog targets | 711 (72%) | CALD1, FGFR2, CKS2, TNPO1, KIAA0101, SPARC, TOP2A, ARHGAP1, B2M, VCAN |
Oct4 targets | 211 (73%) | FGFR2, TCF4, KIAA0101, TOP2A, PPP2R1B, TCF12, UBE2D3, RAB5A, HMGB2, PTPN2 |
Sox2 targets | 542 (74%) | FGFR2, TOP2A, ARHGAP1, VCAN, PPP2R1B, UBE2D3, CBX3, RAB5A, PIK3R3, H2AFX |
NOS targets | 132 (74%) | FGFR2, TOP2A, PPP2R1B, UBE2D3, RAB5A, PTPN2, SET, FGFR1, BUB3, ADD3 |
NOS TFs | 28 (76%) | STAT3, MYST3, IFI16, MLLT10, FOXO1, PHF17, ZFP36L1, TAF12, HHEX, ZEB2 |
NOS co-bound | 199 (56%) | FGFR2, TOP2A, PPP2R1B, UBE2D3, RAB5A, PTPN2, SET, FGFR1, BUB3, BMI1 |
Suz12 targets | 512 (49%) | PDE4DIP, BCL2, GNAS, PTGER3, CD44, RAB31, CYP1B1, EPHB1, GATA3, HLF |
Eed targets | 510 (48%) | PDE4DIP, BCL2, PTGER3, PRKCB, CD44, INPP4A, CYP1B1, EPHB1, GATA3, HLF |
H3K27 bound | 557 (50%) | PDE4DIP, BCL2, PTGER3, PRKCB, EPHB1, GATA3, NTRK2, CD47, GPD1L, NCAM1 |
PRC2 targets | 397 (61%) | PDE4DIP, BCL2, PTGER3, EPHB1, GATA3, NTRK2, NCAM1, CACNA1D, GATA2, GPM6B |
Myc targets1 | 204 (89%) | BCL2, MCM4, TGFB3, CCND2, APC, MUC1, TCF12, ENO1, APP, CSTB |
Myc targets2 | 645 (83%) | CKS2, PPP2R1B, TCF12, UBE2D3, CDC25B, H2AFX, HLA-A, PDK3, PRKDC, TMF1 |
P53 targets | 27 (77%) | GATM, MYH11, TP53, BTG2, INPP5D, MDM2, MYB, SPARCL1, PLK4, FMO5 |